Continuing medical education and disclosures
30 September 2011
Category index
30 September 2011
Abstracts
30 September 2011
Table of contents
30 September 2011
JNK: A double‐edged sword in tumorigenesis
Francisco Javier Cubero, Gang Zhao, Christian Trautwein – 28 September 2011
Border patrol intensifies for hepatitis C virus entry
Erin M. McCartney, Nicholas S. Eyre, Michael R. Beard – 28 September 2011
Noninvasive methods for the assessment of liver fibrosis: A window open on the future?
Massimo Pinzani – 28 September 2011
Hepatitis B virus infection: A strong case against ageism
Daniela C. Kroy, Georg M. Lauer – 28 September 2011
Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve mice
Laurent Dollé, Jan Best, Christophe Empsen, Jie Mei, Elke Van Rossen, Philip Roelandt, Sarah Snykers, Mustapha Najimi, Feras Al Battah, Neil D. Theise, Konrad Streetz, Etienne Sokal, Isabelle A. Leclercq, Catherine Verfaillie, Vera Rogiers, Albert Geerts, Leo A. van Grunsven – 27 September 2011 – The role of progenitor cells in liver repair and fibrosis has been extensively described, but their purification remains a challenge, hampering their characterization and use in regenerative medicine.
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander‐Tetri, Naga Chalasani, Arun J. Sanyal, James E. Nelson, for the NASH Clinical Research Network. – 27 September 2011 – Serum ferritin (SF) levels are commonly elevated in patients with nonalcoholic fatty liver disease (NAFLD) because of systemic inflammation, increased iron stores, or both. The aim of this study was to examine the relationship between elevated SF and NAFLD severity.